Gyre Therapeutics (GYRE) had the highest return between January 31, 2018 and February 9, 2018 by a small-cap US stock, returning 52.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Gyre Therapeutics (GYRE) | 1/31/2018 - 2/9/2018 | 52.73% |
Liquidity Services (LQDT) | 1/31/2018 - 2/9/2018 | 32.99% |
Newegg Commerce (NEGG) | 1/31/2018 - 2/9/2018 | 28.02% |
Red Cat (RCAT) | 1/31/2018 - 2/9/2018 | 25.93% |
InnovAge (INNV) | 1/31/2018 - 2/9/2018 | 24% |
QuinStreet (QNST) | 1/31/2018 - 2/9/2018 | 21.56% |
Contango ORE (CTGO) | 1/31/2018 - 2/9/2018 | 17.3% |
Byrna Technologies (BYRN) | 1/31/2018 - 2/9/2018 | 15.38% |
Cimpress (CMPR) | 1/31/2018 - 2/9/2018 | 12.84% |
Palvella Therapeutics (PVLA) | 1/31/2018 - 2/9/2018 | 12.43% |
Gravity (GRVY) | 1/31/2018 - 2/9/2018 | 12.36% |
Solid Biosciences LLC (SLDB) | 1/31/2018 - 2/9/2018 | 12.25% |
Iovance Biotherapeutics (IOVA) | 1/31/2018 - 2/9/2018 | 11.26% |
EZCORP (EZPW) | 1/31/2018 - 2/9/2018 | 10.97% |
TripAdvisor (TRIP) | 1/31/2018 - 2/9/2018 | 9.49% |
Blue Bird (BLBD) | 1/31/2018 - 2/9/2018 | 9.48% |
Forestar (FOR) | 1/31/2018 - 2/9/2018 | 8.99% |
MCBC (MCFT) | 1/31/2018 - 2/9/2018 | 8.76% |
POET Technologies (POET) | 1/31/2018 - 2/9/2018 | 8.33% |
DiaMedica Therapeutics (DMAC) | 1/31/2018 - 2/9/2018 | 8.32% |
BioCryst Pharmaceuticals (BCRX) | 1/31/2018 - 2/9/2018 | 8.1% |
Cronos (CRON) | 1/31/2018 - 2/9/2018 | 7.53% |
Kelly Services B (KELYB) | 1/31/2018 - 2/9/2018 | 7.41% |
Newell Brands (NWL) | 1/31/2018 - 2/9/2018 | 6.81% |
AMC Entertainment (AMC) | 1/31/2018 - 2/9/2018 | 6.75% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
